Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook

All NewsNovember 3, 2025

Idexx stock gains after Q3 earnings and revenue beat expectations, driven by strong CAG growth and raised 2025 earnings and sales guidance.

Latest Ratings for IDXX

DateFirmActionFromTo Feb 2022Atlantic EquitiesInitiates Coverage OnOverweight Nov 2021Morgan StanleyInitiates Coverage OnOverweight Aug 2021Credit SuisseMaintainsOutperform

View More Analyst Ratings for IDXX

View the Latest Analyst Ratings

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent